Successful Treatment of Interstitial Lung Disease

NOIDA, India - Sept. 29, 2022 - PRLog -- Madhusmita Patro from Odisha was diagnosed with cystic bronchiectasis and recurrent pneumonia (Interstitial Lung Disease). Her condition became chronic over time. Her daily life was severely impacted by the condition. Madhusmita, a banker by profession, could not handle and accomplish her duties due to a severe cough condition. She had a hard time juggling her professional and personal lives.

The abnormal and irreversible deformation of one or more of the conducting bronchi or airways is the outcome of the uncommon disease bronchiectasis, which is typically linked to an infectious infection. Interstitial lung disease (ILD) describes a large group of disorders, most of which cause progressive scarring of lung tissue. The scarring associated with interstitial lung disease eventually affects your ability to breathe and get enough oxygen into your bloodstream.

Madhusmita says, "I tried every method of treatment, but it did not work. I also went to a physician in Visakhapatnam, who told me that -there is no treatment for my condition and I must take medication for the rest of my life. I was devastated "

It was in the year 2020 when she came across Advancells for stem cell therapy. She was guided through the therapy process by Dr Lipi Singh (Vice President, Advancells). Advancells, a research-based company in India, provided stem cell therapy to Madhusmita for her condition and supported her throughout the follow-ups

Patro visited Delhi for the consultation and underwent her first stem cell infusion under the direction of Dr Lipi and her team. After a few months, her condition started to noticeably improve. She now has a higher oxygen level and can walk for up to 1 km without getting weary.  Madhusmita quotes, "I feel no pain, no wheezing, no shortness of breath, and ad my breathing issues have improved so drastically "
Dr Lipi adds, " She has undergone her second stem cell infusion recently (https://www.advancells.com/patientstories/29-years-madhus...) and we are anticipating further improvements in her condition in the coming months. I must say stem cell therapy in combination with exosomes has emerged as a boon for many patients dealing with chronic conditions. I am glad that we are witnessing these improvements."

Vipul Jain, CEO of Advancells, says "Advancells spent years trying for a reliable non-invasive treatment that could benefit from the regenerative potential of our bodies. Patients have seen amazing changes as a result of the therapy for various conditions s and we are proud to provide synergistic solutions to the ailing world."